Filing metadata

Accession number
0001127602-22-028239
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Dec 23, 2022
Reporting period
Apr 25, 2022
Description
Insider transaction

Explore SEC Filings Hub